Literature DB >> 7567788

Seasonal variation in serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in healthy Japanese.

K Wakamatsu1, S Ito.   

Abstract

Serum concentrations of 5-S-cysteinyldopa (5-S-CD) and 6-hydroxy-5-methoxyindole-2-carboxylic acid (6H5MI2C) have been used as biochemical markers of melanoma progression. We examined the effect of solar radiation on serum levels of 5-S-CD and 6H5MI2C in 10 healthy Japanese by measuring these markers every month during a period of 2 years. 5-S-CD levels were higher in early summer and lower in early winter. The difference in the average levels was approximately twofold, but among the 240 samples, no individual values exceeded the upper limit of normal value, 10 nmol/L. A significant correlation (P < 0.02) was observed between 5-S-CD level and solar radiation. 6H5MI2C levels showed a smaller variation than 5-S-CD. No correlation was observed between 6H5MI2C level and solar radiation. This study showed that serum 5-S-CD and 6H5MI2C in healthy Japanese did not exceed the upper limit of normal values even in sunny season.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7567788     DOI: 10.1111/j.1600-0749.1995.tb00653.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  3 in total

1.  Serum levels of S-100 protein and 5-S-cysteinyldopa as markers of melanoma progression.

Authors:  T Bánfalvi; K Gilde; M Boldizsár; T Kremmer; S Ottó
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

2.  Comparison of prognostic significance of serum 5-S-Cysteinyldopa, LDH and S-100B protein in Stage III-IV malignant melanoma.

Authors:  Teodóra Bánfalvi; Mariann Boldizsár; Maria Gergye; Katalin Gilde; Tibor Kremmer; Szabolcs Ottó
Journal:  Pathol Oncol Res       Date:  2003-01-06       Impact factor: 3.201

Review 3.  Significance of 5-S-Cysteinyldopa as a Marker for Melanoma.

Authors:  Kazumasa Wakamatsu; Satoshi Fukushima; Akane Minagawa; Toshikazu Omodaka; Tokimasa Hida; Naohito Hatta; Minoru Takata; Hisashi Uhara; Ryuhei Okuyama; Hironobu Ihn
Journal:  Int J Mol Sci       Date:  2020-01-09       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.